Brain differences in first-episode schizophrenia treated with quetiapine: A deformation-based morphometric study

Psychopharmacology

Volumn 232, Issue 2, 2015, Pages 369-377

  Yang, Chunlan ^a   Wu, Shuicai ^a   Lu, Wangsheng ^b   Bai, Yanping ^a   Gao, Hongjian ^a  

^a BEIJING UNIVERSITY OF TECHNOLOGY   (China)

^b NAVY GENERAL HOSPITAL   (China)

Author keywords

Brain; MRI; Neuroimaging; Schizophrenia; Structure

Indexed keywords

NEUROLEPTIC AGENT; QUETIAPINE; DIBENZOTHIAZEPINE DERIVATIVE;

ADULT; ARTICLE; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; TEMPORAL GYRUS; THREE DIMENSIONAL IMAGING; TREATMENT DURATION; VOXEL BASED MORPHOMETRY; BRAIN; BRAIN CORTEX; CASE CONTROL STUDY; DRUG EFFECTS; HEMISPHERIC DOMINANCE; OCCIPITAL LOBE; PATHOLOGY; PROCEDURES; PSYCHOTIC DISORDERS; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DIBENZOTHIAZEPINES; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OCCIPITAL LOBE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84926454469     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3670-7     Document Type: Article

References (54)

1. Andreasen NC, Pierson R. (2008) The role of the cerebellum in schizophrenia. Biol Psychiat 64:81-88
2. Angelucci F, Aloe L, Iannitelli A et al (2005) Effect of chronic olanzapine treatment on nerve growth factor and brain-derived neurotrophic factor in the rat brain. Eur Neuropsychopharmacol 15:311-317
3. Ashburner J, Friston K.J. (2004) High-dimensional image warping. In: Frackowiak R, editor. Human brain function. 2nd edn. Academic Press, pp 673-694
4. Chew SH, Ho J.L. (1994) Hope: an empirical study of attitude toward the timing of uncertainty resolution. J Risk Uncertain 8:267-288
5. Cosi C, Waget A, Rollet K et al (2005) Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation. Brain Res 1043:32-41
6. Crespo-Facorro B., Roiz-Santianez R, Perez-Iglesias R et al (2008) Effect of antipsychotic drugs on brain morphometry: a randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 32: 1936-1943
7. Davatzikos C, Vaillant M, Resnick SM et al (1996) A computerized approach for morphological analysis of the corpus callosum. J Comput Assist Tomogr 20:88-97
8. Ding SL, Van HGW, Cassell MD et al (2009) Parcellation of human temporal polar cortex: a combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers. J Comp Neurol 514:595-623
9. Ebdrup BH, Glenthøj B, Rasmussen H et al (2010) Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia. J Psychiatry Neurosci 35:95-104
10. Ebdrup BH, Skimminge A, Rasmussen H et al (2011) Progressive striatal and hippocampal volume loss in initially antipsychotic-naïve, firstepisode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 14:69-82
11. Ellison-Wright L., Glahn DC, Laird AR et al (2008) The anatomy of firstepisode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 165:1015-1023
12. Fabre LF J.r., Arvanitis L, Pultz J et al (1995) ICI 204, 636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clin Ther 17: 366-378
13. Farmer CM, O'Donnell BF, Niznikiewicz MA et al (2000) Visual perception and working memory in schizotypal personality disorder. Am J Psychiatry 157:781-788
14. First M, Spitzer R, Gibbon M., et al. (1995) Structured clinical interview for DSM-IVAxis I Disorder-Patient Edition (SCID-I/P, Version 2.0), Biometrics Research Department, New York State Psychiatric Institute. New York
15. Fornito A, Yücel M, Patti J et al (2009) Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108:104-113
16. Fumagalli F, Molteni R, Bedogni F et al (2004) Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801. Neuroreport 15:2109-2112
17. Gaser C, Volz HP, Kiebel S et al (1999) Detecting structural changes in whole brain based on nonlinear deformations: application to schizophrenia research. Neuroimage 10:107-113
18. Glahn DC, Laird AR, Ellison-Wright L et al (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiat 64:774-781
19. Halim ND, Weickert CS, McClintock BW et al (2004) Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29:1063-1069
20. Jacobsen LK, Giedd JN, Vaituzis AC et al (1996) Temporal lobe morphology in childhood-onset schizophrenia. Am J Psychiat 153:355-361
21. Kasai K, Shenton ME, Salisbury DF et al (2003) Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiat 160:156-164
22. Kašpárek T, Mareček R, Schwarz D et al (2010) Source-based morphometry of gray matter volume in men with first-episode schizophrenia. Hum Brain Mapp 31:300-310
23. Kay SR, Fiszbein A, Opler L.A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 13:261-276
24. Keshavan MS, Haas GL, Kahn CE et al (1998) Superior temporal gyrus and the course of early schizophrenia: progressive, static, or reversible? J Psychiatr Res 32:161-167
25. Kumra S, Giedd JN, Vaituzis AC et al (2000) Childhood-onset psychotic disorders magnetic resonance imaging of volumetric differences in brain structure. Am J Psychiat 157:1467-1474
26. Laakso MP, Tiihonen J, Syvalahti E et al (2001) A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia. Schizophr Res 50:3-7
27. Levitt JJ, McCarley RW, Nestor PG et al (1999) Quantitative volumetric MRI study of the cerebellum and vermis in schizophrenia: clinical and cognitive correlates. Am J Psychiat 156:1105-1107
28. Levitt JG, Blanton RE, Caplan R et al (2001) Medial temporal lobe in childhood-onset schizophrenia. Psychiat Res 108:17-27
29. Lewis DA, Lieberman J.A. (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325-334
30. McEvoy JP, Lieberman JA, Perkins DO et al (2007) Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 164:1050-1060
31. Millan MJ (2005) N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) 179:30-53
32. Mitelman SA, Shihabuddin L, Brickman AM et al (2003) MRI assessment of gray and white matter distribution in Brodmann's areas of the cortex in patients with schizophrenia with good and poor outcomes. Am J Psychiat 160:2154-2168
33. Newton SS, Duman R.S. (2007) Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 21:715-725
34. Ohnishi T, Hashimoto R, Mori T et al (2006) The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129:399-410
35. Purdon SE, Malla A, Labelle A et al (2001) Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol. J Psychiatry Neurosci 26:137-149
36. Riedel M, Müller N, Strassnig M et al (2007) Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatr Dis Treat 3: 219-235
37. Rimol LM, Hartberg CB, Nesvag R et al (2010) Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol psychiat 68:41-50
38. Shattuck DW, Leahy R.M. (2001) Graph based analysis and correction of cortical volume topology. IEEE Trans Med Imaging 20:1167-1177
39. Shen DG, Davatzikos C. (2002) HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE T Med Imaging 21:1421-1439
40. Shen D, Liu D, Liu H et al (2004) Automated morphometric study of brain variation in XXY males. Neuroimage 23:648-653
41. Small JG, Hirsch SR, Arvanitis LA et al (1997) Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel study group. Arch Gen Psychiatry 54:549-557
42. Steen RG, Mull C, McClure R et al (2006) Brain volume in firstepisode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188: 510-518
43. Takahashi T, Suzuki M, Tanino R et al (2007) Volume reduction of the left planum temporal gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiat Res 154:209-219
44. Tarazi FI, Zhang K, Baldessarini R.J. (2001) Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther 297:711-717
45. Taylor JL, Blanton RE, Levitt JG et al (2005) Superior temporal gyrus differences in childhood-onset schizophrenia. Schizophr Res 73: 235-241
46. Tek C, Gold J, Blaxton T et al (2002) Visual perceptual and working memory impairments in schizophrenia. Arch Gen Psychiatry 59: 146-153
47. Vita A, De Peri L (2007) Hippocampal and amygdala volume reductions in first-episode schizophrenia. Br J Psychiatry 190:271
48. Vita A, De Peri L, Silenzi C et al (2006) Brain morphology in firstepisode schizophrenia: a meta analysis of quantitative magnetic resonance imaging studies. Schizophr Res 82:75-88
49. Volz KG, Schubotz RL, Cramon D.Y. (2005) Variants of uncertainty in decision-making and their neural correlates. Brain Res Bull 67:403-412
50. Wang HD, Dunnavant FD, Jarman T et al (2004) Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 29:1230-1238
51. Whitford TJ, Grieve SM, Farrow TFD et al (2006) Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 32:511-519
52. Whitford TJ, Grieve SM, Farrow TFD et al (2007) Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am J Psychiatry 164:1082-1089
53. Whitwell JL (2009) Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J Neurosci 29:9661-9664
54. Yamada M, Hirao K, Namiki C et al (2007) Social cognition and frontal lobe pathology in schizophrenia: a voxel-based morphometric study. Neuroimage 35:292-298